TY - JOUR
T1 - Neuroprotective Mechanisms of the ACE2-Angiotensin-(1-7)-Mas Axis in Stroke
AU - Bennion, Douglas M
AU - Haltigan, Emily
AU - Regenhardt, Robert W
AU - Steckelings, Ulrike Muscha
AU - Sumners, Colin
PY - 2015/2
Y1 - 2015/2
N2 - The discovery of beneficial neuroprotective effects of the angiotensin converting enzyme 2-angiotensin-(1-7)-Mas axis [ACE2-Ang-(1-7)-Mas] in ischemic and hemorrhagic stroke has spurred interest in a more complete characterization of its mechanisms of action. Here, we summarize findings that describe the protective role of the ACE2-Ang-(1-7)-Mas axis in stroke, along with a focused discussion on the potential mechanisms of neuroprotective effects of Ang-(1-7) in stroke. The latter incorporates evidence describing the actions of Ang-(1-7) to counter the deleterious effects of angiotensin II (AngII) via its type 1 receptor, including anti-inflammatory, anti-oxidant, vasodilatory, and angiogenic effects, and the role of altered kinase-phosphatase signaling. Interactions of Mas with other receptors, including bradykinin receptors and AngII type 2 receptors are also considered. A more complete understanding of the mechanisms of action of Ang-(1-7) to elicit neuroprotection will serve as an essential step toward research into potential targeted therapeutics in the clinical setting.
AB - The discovery of beneficial neuroprotective effects of the angiotensin converting enzyme 2-angiotensin-(1-7)-Mas axis [ACE2-Ang-(1-7)-Mas] in ischemic and hemorrhagic stroke has spurred interest in a more complete characterization of its mechanisms of action. Here, we summarize findings that describe the protective role of the ACE2-Ang-(1-7)-Mas axis in stroke, along with a focused discussion on the potential mechanisms of neuroprotective effects of Ang-(1-7) in stroke. The latter incorporates evidence describing the actions of Ang-(1-7) to counter the deleterious effects of angiotensin II (AngII) via its type 1 receptor, including anti-inflammatory, anti-oxidant, vasodilatory, and angiogenic effects, and the role of altered kinase-phosphatase signaling. Interactions of Mas with other receptors, including bradykinin receptors and AngII type 2 receptors are also considered. A more complete understanding of the mechanisms of action of Ang-(1-7) to elicit neuroprotection will serve as an essential step toward research into potential targeted therapeutics in the clinical setting.
KW - Angiotensin converting enzyme 2
KW - Angiotensin type 1 receptor
KW - Angiotensin type 2 receptor
KW - Angiotensin-(1-7)
KW - Inflammation
KW - Intracerebral hemorrhage
KW - Ischemia
KW - Mas
KW - Microglia
KW - Neuron
KW - Neuroprotection
KW - Renin-angiotensin system
KW - Stroke
KW - Peptidyl-Dipeptidase A/metabolism
KW - Angiotensin I/metabolism
KW - Humans
KW - Neuroprotective Agents/pharmacology
KW - Signal Transduction/drug effects
KW - Animals
KW - Stroke/metabolism
KW - Peptide Fragments/metabolism
U2 - 10.1007/s11906-014-0512-2
DO - 10.1007/s11906-014-0512-2
M3 - Journal article
C2 - 25620630
SN - 1522-6417
VL - 17
JO - Current Hypertension Reports
JF - Current Hypertension Reports
M1 - 3
ER -